前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写(冊子体のコピー)をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID:202102272202766492   整理番号:21A1436350

非小細胞肺癌におけるPD-1遮断反応の潜在的予測バイオマーカーとしてのRAD51Bmeレベル【JST・京大機械翻訳】

RAD51Bme Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer
著者 (19件):
Guerreiro Ines Maria
(Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Barros-Silva Daniela
(Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Lopes Paula
(Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Lopes Paula
(Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Cantante Mariana
(Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Cantante Mariana
(Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Cunha Ana Luisa
(Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Cunha Ana Luisa
(Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Lobo Joao
(Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Lobo Joao
(Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Lobo Joao
(Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, Portugal)
Antunes Luis
(Cancer Epidemiology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Rodrigues Ana
(Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Soares Marta
(Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Henrique Rui
(Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Henrique Rui
(Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Henrique Rui
(Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, Portugal)
Jeronimo Carmen
(Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Antonio Bernardino de Almeida, 4200-072 Porto, Portugal)
Jeronimo Carmen
(Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, Portugal)

資料名:
Journal of Clinical Medicine (Web)  (Journal of Clinical Medicine (Web))

巻:号:ページ: 1000  発行年: 2020年 
JST資料番号: U7214A  ISSN: 2077-0383  資料種別: 逐次刊行物 (A)
記事区分: 原著論文  発行国: スイス (CHE)  言語: 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写(コピー)して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写(コピー)は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。